Literature DB >> 16083270

Discovery of biomarker candidates within disease by protein profiling: principles and concepts.

György Marko-Varga1, Henrik Lindberg, Claes-Göran Löfdahl, Per Jönsson, Lennart Hansson, Magnus Dahlbäck, Eva Lindquist, Leif Johansson, Martyn Foster, Thomas E Fehniger.   

Abstract

Proteins and peptides present within clinical samples represent a valuable library of information regarding the ongoing processes within cells and tissues in health and disease. We have developed and validated novel technology applications that can be used to characterize the patterns of global protein expression in tissue and biofluids in either gel-based systems or by automated multidimensional nanocapillary liquid chromatography. Mass spectrophotometry platforms using MALDI MS and MS/MS or LTQ ion trap MS were capable of delivering sensitive and accurate identifications of hundreds of proteins contained in individual samples including individual forms of processing intermediates such as phospho peptides. The Systems Biology approach of integrating protein expression data with clinical data such as histopathology, clinical functional measurements, medical imaging scores, patient demographics, and clinical outcome provides a powerful tool for linking biomarker expression with biological processes that can be segmented and linked to disease presentation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083270     DOI: 10.1021/pr050122w

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  17 in total

Review 1.  MALDI imaging mass spectrometry: state of the art technology in clinical proteomics.

Authors:  Julien Franck; Karim Arafah; Mohamed Elayed; David Bonnel; Daniele Vergara; Amélie Jacquet; Denis Vinatier; Maxence Wisztorski; Robert Day; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2009-05-18       Impact factor: 5.911

Review 2.  Nanostructure-initiator mass spectrometry metabolite analysis and imaging.

Authors:  Matthew P Greving; Gary J Patti; Gary Siuzdak
Journal:  Anal Chem       Date:  2010-11-04       Impact factor: 6.986

3.  Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis.

Authors:  Jiyan Liu; Tingting Jiang; Feng Jiang; Dandan Xu; Liliang Wei; Chong Wang; Zhongliang Chen; Xing Zhang; Jicheng Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  CONSeQuence: prediction of reference peptides for absolute quantitative proteomics using consensus machine learning approaches.

Authors:  Claire E Eyers; Craig Lawless; David C Wedge; King Wai Lau; Simon J Gaskell; Simon J Hubbard
Journal:  Mol Cell Proteomics       Date:  2011-08-03       Impact factor: 5.911

5.  Chromosome 19 annotations with disease speciation: a first report from the Global Research Consortium.

Authors:  Carol L Nilsson; Frode Berven; Frode Selheim; Huiling Liu; Joseph R Moskal; Roger A Kroes; Erik P Sulman; Charles A Conrad; Frederick F Lang; Per E Andrén; Anna Nilsson; Elisabet Carlsohn; Hans Lilja; Johan Malm; David Fenyö; Devipriya Subramaniyam; Xiangdong Wang; Maria Gonzales-Gonzales; Noelia Dasilva; Paula Diez; Manuel Fuentes; Ákos Végvári; Karin Sjödin; Charlotte Welinder; Thomas Laurell; Thomas E Fehniger; Henrik Lindberg; Melinda Rezeli; Goutham Edula; Sophia Hober; György Marko-Varga
Journal:  J Proteome Res       Date:  2012-12-18       Impact factor: 4.466

6.  Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria.

Authors:  Junichi Kamiie; Sumio Ohtsuki; Ryo Iwase; Ken Ohmine; Yuki Katsukura; Kazunari Yanai; Yumi Sekine; Yasuo Uchida; Shingo Ito; Tetsuya Terasaki
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 7.  Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies.

Authors:  Philip Alex; Marjan Gucek; Xuhang Li
Journal:  Inflamm Bowel Dis       Date:  2009-04       Impact factor: 5.325

8.  Nanostructure initiator mass spectrometry: tissue imaging and direct biofluid analysis.

Authors:  Oscar Yanes; Hin-Koon Woo; Trent R Northen; Stacey R Oppenheimer; Leah Shriver; Jon Apon; Mayra N Estrada; Michael J Potchoiba; Rick Steenwyk; Marianne Manchester; Gary Siuzdak
Journal:  Anal Chem       Date:  2009-04-15       Impact factor: 6.986

9.  Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels.

Authors:  Melinda Rezeli; Akos Végvári; Thomas E Fehniger; Thomas Laurell; György Marko-Varga
Journal:  J Clin Bioinforma       Date:  2011-02-08

10.  Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine.

Authors:  György Marko-Varga; Akos Végvári; Melinda Rezeli; Kaiu Prikk; Peeter Ross; Magnus Dahlbäck; Goutham Edula; Ruth Sepper; Thomas E Fehniger
Journal:  Clin Transl Med       Date:  2012-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.